Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02974257 · ClinicalTrials.gov registry record · Phase 2
Thiamine vs. Placebo to Increase Oxygen Consumption After Cardiac Arrest
A Phase 2 study, sponsored by Beth Israel Deaconess Medical Center.
- Terminated
- Registry status
- Phase 2
- Development phase
- 41
- Enrollment target
NCT02974257 is a Phase 2 study that was terminated before completion, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 41 participants.
The verdict
NCT02974257, a Phase 2 study, was terminated before completion, sponsored by Beth Israel Deaconess Medical Center.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 41 participants
- Enrollment target
Study Summary
This study is to evaluate whether thiamine can increase oxygen consumption and lower lactate in patients who initially survive an in-hospital cardiac arrest. Patients who are successfully resuscitated after an in-hospital cardiac arrest and who are on mechanical ventilation in the intensive care unit will be enrolled, and will get either thiamine or placebo. Their oxygen consumption and lactate will be measured at serial time points and compared between groups. The investigators' hypothesis is that thiamine will help restore the body's ability to metabolize oxygen normally (aerobic metabolism), leading to an increase in oxygen consumption and a decrease in lactate.
Interventions
- OTHER placebo
- DRUG Thiamine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2017-05-01 |
| Est. Completion | 2022-08-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02974257
The ClinicalTrials.gov registry entry for NCT02974257 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT02974257 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02974257 about?
NCT02974257 is a clinical study titled "Thiamine vs. Placebo to Increase Oxygen Consumption After Cardiac Arrest". This study is to evaluate whether thiamine can increase oxygen consumption and lower lactate in patients who initially survive an in-hospital cardiac arrest. Patients who are successfully resuscitated after an in-hospital cardiac arrest and who are on mechanical ventilation in the intensive care uni...
What is the current status of trial NCT02974257?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 41 participants. The study started on 2017-05-01. Estimated completion is 2022-08-01.
What interventions are being tested in trial NCT02974257?
The interventions under investigation include: placebo (OTHER), Thiamine (DRUG).
Who is sponsoring clinical trial NCT02974257?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.